Download PDF
Thromb Haemost 2013; 110(01): 197-199
DOI: 10.1160/TH13-02-0112
Letters to the Editor
Schattauer GmbH

Non-O blood group as a risk factor for cerebral vein thrombosis

Antonella Tufano
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Antonio Coppola
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Assunta Nardo
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Carlo Bonfanti
2   Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy
,
Silvia Crestani
2   Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy
,
Anna Maria Cerbone
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Massimo Franchini
2   Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy
› Author Affiliations
Further Information

Publication History

Received: 09 February 2013

Accepted after minor revision: 21 March 2013

Publication Date:
30 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Stam J. Thrombosis of the cerebral vein and sinuses. N Eng J Med 2005; 352: 1791-1798.
    CrossrefPubMedGoogle Scholar
  • 2 Tait C, Baglin T, Watson H. et al. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol 2012; 159: 28-38.
    CrossrefPubMedGoogle Scholar
  • 3 Martinelli I, Sacchi E, Landi G. et al. High risk of cerebral vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Eng J Med 1998; 338: 1793-1797.
    CrossrefPubMedGoogle Scholar
  • 4 Madonna P, De Stefano V, Coppola A. et al. G20210A prothrombin gene mutation and other thrombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke 2000; 31: 1787-1788.
    PubMedGoogle Scholar
  • 5 Tufano A, Guida A, Coppola A. et al. Risk factors and recurrent thrombotic episodes in patients with cerebral vein thrombosis. Blood Transfusion. 2013 Epub ahead of print.
    PubMedGoogle Scholar
  • 6 Jick H, Slone D, Westerholm B. et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969; 01: 539-542.
    PubMedGoogle Scholar
  • 7 Wautrecht JC, Galle C, Motte S. et al. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998; 79: 688-689.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Tirado I, Mateo J, Soria JM. et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005; 93: 468-474.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Trégouët DA, Heath S, Saut N. et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009; 113: 5298-5303.
    CrossrefPubMedGoogle Scholar
  • 10 Germain M, Saut N, Greliche N. et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE 2011; 06: e25581.
    CrossrefPubMedGoogle Scholar
  • 11 Wu O, Bayoumi N, Vickers MA. et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 06: 62-69.
    PubMedGoogle Scholar
  • 12 Dentali F, Sironi AP, Ageno W. et al. Non-O blood type is the commonest genetic risk factor for VTE: Results from a meta-analysis of the literature. Semin Thromb Hemost 2012; 38: 535-548.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Franchini M, Makris M. Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus. 2012 Epub ahead of print.
    PubMedGoogle Scholar
  • 14 Koster T, Blann AD, Briet E. et al. Role of clotting factor VIII in eWillebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost 2006; 04: 2556-2562.
    CrossrefPubMedGoogle Scholar
  • 15 Moeller A, Weippert-Kretschmer M, Prinz H. et al. Influence of AB0 blood group on primary haemostasis. Transfusion 2001; 41: 56-60.
    CrossrefPubMedGoogle Scholar
  • 16 Spiezia L, Campello E, Bon M. et al. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus. 2012 Epub ahead of print.
    PubMedGoogle Scholar
  • 17 Cohen W, Castelli C, Alessi M-C. et al. ABO group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia. Arterioscler Thromb Vasc Biol 2012; 32: 2021-2028.
    CrossrefPubMedGoogle Scholar
  • 18 Miñano A, Ordóñez A, España F. et al. ABO blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica 2008; 93: 729-734.
    CrossrefPubMedGoogle Scholar